Susan Moran Bio Atla, Inc. (BCAB) insider trading activity

BCAB Quotes by TradingView

Susan Moran is of BioAtla, Inc.. Currently has a direct ownership of 52,307 shares of BCAB, which is worth approximately $18,307. The most recent transaction as insider was on Jun 18, 2025, when has been sold 23,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.3K
81.58% 3M change
81.58% 12M change
Total Value Held $18,307

Susan Moran Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
BUY
Grant, award, or other acquisition
-
23,500 Added 31.0%
52,307 Common Stock
Jun 13 2024
BUY
Grant, award, or other acquisition
-
16,500 Added 36.42%
28,807 Common Stock

Also insider at

TYRA
Tyra Biosciences, Inc. Healthcare
GLYC
GLYCOMIMETICS INC Healthcare
Director
RYZB
RayzeBio, Inc.
CHIEF MEDICAL OFFICER
SM

Susan Moran

San Diego, CA

Track Institutional and Insider Activities on BCAB

Follow BioAtla, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCAB shares.

Notify only if

Insider Trading

Get notified when an Bio Atla, Inc. insider buys or sells BCAB shares.

Notify only if

News

Receive news related to BioAtla, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCAB